Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0002080346-25-000001
Filing Date
2025-08-07
Accepted
2025-08-07 14:20:35
Documents
1
Effectiveness Date
2025-08-07
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.1: Section 3(c)(1)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 6089
  Complete submission text file 0002080346-25-000001.txt   7346
Mailing Address 2093 PHILADELPHIA PIKE 5885 CLAYMONT DE 19703
Business Address 2093 PHILADELPHIA PIKE 5885 CLAYMONT DE 19703 (360) 946-0604
CAN Belhaven BioPharma Series A a Series of CGF2021 LLC (Filer) CIK: 0002080346 (see all company filings)

EIN.: 393097116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-554017 | Film No.: 251193216